Serum amyloid P-component
OrganismNot specified
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein homooligomer Homooligomer Protein × 5 PDB declaration: pentameric(5) Consistent with protein copy count | Chain A; UniProt 20–223 Chain B; UniProt 20–223 Chain C; UniProt 20–223 Chain D; UniProt 20–223 Chain E; UniProt 20–223 | Not recorded | CA CALCIUM ION × 10 CPJ BIS-1,2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE × 5 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;pH 5.5;294 K;sodium actetate, calcium acetate, PEG 8000, PEG 400, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K | Resolution 2.00 Å R-free 0.250 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 2A3Y | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1GYK Serum Amyloid P Component co-crystallised with MOBDG at neutral pH Deposited 2002-04-25 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain A
20–223(204 aa)
Chain B
20–223(204 aa)
Chain C
20–223(204 aa)
Chain D
20–223(204 aa)
Chain E
20–223(204 aa)
|
Not recorded | CA CALCIUM ION × 9 CDG METHYL 4,6-O-[(1R)-1-CARBOXYETHYLIDENE]-BETA-D-GALACTOPYRANOSIDE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;pH 8.00
|
Resolution 2.20 Å R-free 0.224 |
| 1LGN DECAMERIC DAMP COMPLEX OF HUMAN SERUM AMYLOID P COMPONENT Deposited 1996-12-04 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain A
20–223(204 aa)
Chain B
20–223(204 aa)
Chain C
20–223(204 aa)
Chain D
20–223(204 aa)
Chain E
20–223(204 aa)
|
Not recorded | CA CALCIUM ION × 10 D5M 2'-DEOXYADENOSINE-5'-MONOPHOSPHATE × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;277 K;3 + 3 UL HANGING DROPS AT 277K PROTEIN SOLUTION: 20 MG/ML PROTEIN, 10 MM TRIS-HCL, PH 8.0, 140 MM NACL, 20 MM DAMP, 0.02 % NA-AZIDE. RESERVOIR SOLUTION: 100 MM BIS-TRIS PROPANE- HCL PH 8.0, 20 MM CALCIUM CHLORIDE, 12-14 % (W/V) POLYETHYLENEGLYCOL 4000., vapor diffusion - hanging drop
|
Resolution 2.80 Å R-free 0.252 |
| 1SAC THE STRUCTURE OF PENTAMERIC HUMAN SERUM AMYLOID P COMPONENT Deposited 1994-01-27 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain A
20–223(204 aa)
Chain B
20–223(204 aa)
Chain C
20–223(204 aa)
Chain D
20–223(204 aa)
Chain E
20–223(204 aa)
|
Not recorded | CA CALCIUM ION × 10 ACY ACETIC ACID × 4 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.00 Å |
| 2A3W Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane Deposited 2005-06-27 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 10 PDB declaration: decameric |
Chain A
20–223(204 aa)
Chain B
20–223(204 aa)
Chain C
20–223(204 aa)
Chain D
20–223(204 aa)
Chain E
20–223(204 aa)
Chain F
20–223(204 aa)
Chain G
20–223(204 aa)
Chain H
20–223(204 aa)
Chain I
20–223(204 aa)
Chain J
20–223(204 aa)
|
Not recorded | CA CALCIUM ION × 20 CPJ BIS-1,2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;294 K;PEG 4000, PEG 400, sodium acetate, calcium acetate, sorbitol, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 2.20 Å R-free 0.229 |
| 2A3W Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane Deposited 2005-06-27 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 10 PDB declaration: decameric |
Chain K
20–223(204 aa)
Chain L
20–223(204 aa)
Chain M
20–223(204 aa)
Chain N
20–223(204 aa)
Chain O
20–223(204 aa)
Chain P
20–223(204 aa)
Chain Q
20–223(204 aa)
Chain R
20–223(204 aa)
Chain S
20–223(204 aa)
Chain T
20–223(204 aa)
|
Not recorded | CA CALCIUM ION × 20 CPJ BIS-1,2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;294 K;PEG 4000, PEG 400, sodium acetate, calcium acetate, sorbitol, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 2.20 Å R-free 0.229 |
| 2A3X Decameric crystal structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2carboxy- 2-methyl-1,3-dioxane]- 5-yloxycarbonyl}-piperazine Deposited 2005-06-27 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 10 PDB declaration: decameric |
Chain A
20–223(204 aa)
Chain B
20–223(204 aa)
Chain C
20–223(204 aa)
Chain D
20–223(204 aa)
Chain E
20–223(204 aa)
Chain F
20–223(204 aa)
Chain G
20–223(204 aa)
Chain H
20–223(204 aa)
Chain I
20–223(204 aa)
Chain J
20–223(204 aa)
|
Not recorded | CA CALCIUM ION × 20 CPK BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBONYL}-PIPERAZINE × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;294 K;sodium acetate, calcium acetate, PEG 8000, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 3.00 Å R-free 0.282 |
| 2W08 The structure of serum amyloid P component bound to 0-phospho- threonine Deposited 2008-08-12 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain A
20–223(204 aa)
Chain B
20–223(204 aa)
Chain C
20–223(204 aa)
Chain D
20–223(204 aa)
Chain E
20–223(204 aa)
|
Not recorded | CA CALCIUM ION × 10 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 TPO PHOSPHOTHREONINE × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;0.06M TRIS-HCL PH8, 16% PEG 550MME, 0.01M CACL2, 0.08M NACL, 0.1% NAN3, 14.2MG/ML PROTEIN, 50MM LIGAND
|
Resolution 1.70 Å R-free 0.176 |
| 3D5O Structural recognition and functional activation of FcrR by innate pentraxins Deposited 2008-05-16 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain A
20–223(204 aa)
Chain B
20–223(204 aa)
Chain C
20–223(204 aa)
Chain D
20–223(204 aa)
Chain E
20–223(204 aa)
|
Not recorded | SO4 SULFATE ION × 16 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 GOL GLYCEROL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;2.0 M NH4SO4, 5% iso-propanol, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.80 Å R-free 0.279 |
| 3KQR The structure of serum amyloid p component bound to phosphoethanolamine Deposited 2009-11-17 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain A
20–223(204 aa)
Chain B
20–223(204 aa)
Chain C
20–223(204 aa)
Chain D
20–223(204 aa)
Chain E
20–223(204 aa)
|
Not recorded | OPE PHOSPHORIC ACID MONO-(2-AMINO-ETHYL) ESTER × 5 CA CALCIUM ION × 10 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;0.06M TRIS-HCL pH8, 16% PEG 550MME, 0.01M CaCl2, 0.14M NaCl, 0.1% NaN3,14.2mg/ml Protein, 0.05M Ligand, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 1.50 Å R-free 0.161 |
| 4AVS Structure of N-Acetyl-L-Proline bound to Serum Amyloid P Component Deposited 2012-05-29 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain A
20–223(204 aa)
Chain B
20–223(204 aa)
Chain C
20–223(204 aa)
Chain D
20–223(204 aa)
Chain E
20–223(204 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 CA CALCIUM ION × 10 N7P 1-ACETYL-L-PROLINE × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;0.06 M TRIS-HCL, PH 8, 16% PEG 550 MME, 0.01 M CACL2, 0.08 M NACL AND 0.1% NAN3
|
Resolution 1.40 Å R-free 0.170 |
| 4AVT Structure of CPHPC bound to Serum Amyloid P Component Deposited 2012-05-29 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain A
20–223(204 aa)
Chain C
20–223(204 aa)
Chain E
20–223(204 aa)
Chain G
20–223(204 aa)
Chain I
20–223(204 aa)
|
Not recorded | CA CALCIUM ION × 10 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 GHE (2R)-1-[6-[(2R)-2-carboxypyrrolidin-1-yl]-6-oxidanylidene-hexanoyl]pyrrolidine-2-carboxylic acid × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.6;60MM TRIS-HCL, 80MM NACL, 15% PEG550 MME, pH 7.6
|
Resolution 3.20 Å R-free 0.197 |
| 4AVT Structure of CPHPC bound to Serum Amyloid P Component Deposited 2012-05-29 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain B
20–223(204 aa)
Chain D
20–223(204 aa)
Chain F
20–223(204 aa)
Chain H
20–223(204 aa)
Chain J
20–223(204 aa)
|
Not recorded | CA CALCIUM ION × 10 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 GHE (2R)-1-[6-[(2R)-2-carboxypyrrolidin-1-yl]-6-oxidanylidene-hexanoyl]pyrrolidine-2-carboxylic acid × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.6;60MM TRIS-HCL, 80MM NACL, 15% PEG550 MME, pH 7.6
|
Resolution 3.20 Å R-free 0.197 |
| 4AVV Structure of CPHPC bound to Serum Amyloid P Component Deposited 2012-05-29 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain A
20–223(204 aa)
Chain B
20–223(204 aa)
Chain C
20–223(204 aa)
Chain D
20–223(204 aa)
Chain E
20–223(204 aa)
|
Not recorded | ACT ACETATE ION × 8 GHE (2R)-1-[6-[(2R)-2-carboxypyrrolidin-1-yl]-6-oxidanylidene-hexanoyl]pyrrolidine-2-carboxylic acid × 5 CD CADMIUM ION × 35 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 SIA N-acetyl-alpha-neuraminic acid × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.6;PH 4.6
|
Resolution 1.60 Å R-free 0.175 |
| 4AYU Structure of N-Acetyl-D-Proline bound to serum amyloid P component Deposited 2012-06-22 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain A
20–223(204 aa)
Chain B
20–223(204 aa)
Chain C
20–223(204 aa)
Chain D
20–223(204 aa)
Chain E
20–223(204 aa)
|
Not recorded | CA CALCIUM ION × 10 N8P N-ACETYL-D-PROLINE × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 GOL GLYCEROL × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;60 MM TRIS-HCL PH 8.0, 10 MM CACL2, 84 MM NACL, 20% GLYCEROL V/V, 17% PEG550 MME V/V
|
Resolution 1.50 Å R-free 0.168 |
12 other PDB entries and 14 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | SAMP_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–204; UniProt 20–223 Author chain B; PDBConstruct 1–204; UniProt 20–223 Author chain C; PDBConstruct 1–204; UniProt 20–223 Author chain D; PDBConstruct 1–204; UniProt 20–223 Author chain E; PDBConstruct 1–204; UniProt 20–223 |